GlassScriptPhysician profile
Hohai T Van
NPI 1780761965
$1,952.66
in general payments reported to CMS, 2019-2025
16 companies · $845 in 2025
The $845 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $181 · 2022: $140 · 2023: $212 · 2024: $247 · 2025: $845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,092 · Education: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.45 |
| Education | $212.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $531.63 | 2023-2025 | Abilify, Camzyos, Eliquis |
| Biotronik INC. | $330.69 | 2020-2025 | Biomonitor |
| Amgen INC. | $274.47 | 2019-2025 | Repatha, Repatha |
| Cvrx, INC. | $158.98 | 2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $145.02 | 2025 | |
| Boston Scientific Corporation | $114.40 | 2019 | |
| Pfizer INC. | $85.36 | 2024-2025 | |
| Abbott Laboratories | $59.68 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.66 | 2025 | Jardiance |
| Philips North America LLC | $50.90 | 2024-2025 | (Ck7) Extended Holter, Ecc Solutions |
| Cleerly, INC. | $36.80 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Alnylam Pharmaceuticals INC. | $29.37 | 2024 | Amvuttra |
| Cardiva Medical, INC. | $24.22 | 2024 | Savvywire |
| Cardiovascular Systems INC. | $22.73 | 2019 | |
| Kestra Medical Technology Services, INC. | $15.63 | 2024 | Assure Wcd |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $15.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hohai Van listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.